Zai Lab To Present Preliminary Data From Phas ...

Zai Lab (ZLAB) Limited announced that it has commenced an underwritten public offering of $200M of American depositary shares, ADSs, each representing ten ordinary shares of the company with a par ...

Scotiabank initiated coverage of Zai Lab (ZLAB) with an Outperform rating and $55 price target The firm says that although geopolitical risk has capped the stock’s upside for years, Zai Lab is ...

Zai Lab (ZLAB) and Pfizer (PFE) announced a strategic collaboration for the novel antibacterial drug Xacduro in mainland China. Pfizer’s affiliated companies will be exclusively authorized to ...

Zai Lab Ltd (HK:9688) has released an update. Zai Lab Ltd is set to offer 7,843,137 American Depositary Shares (ADS), representing 78,431,370 underlying shares, as part of a new issuance under a ...